| Species | Human |
| Product Type | iPS-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Gastric |
| Disease | Normal |
| Generation Process | Human gastric organoids are generated from both primary tissue samples and induced pluripotent stem cells (iPSCs) using advanced stem cell technologies. Precise differentiation protocols enable the production of highly functional, physiologically relevant gastric organoids that serve as invaluable tools for experimental research and therapeutic development. |
| Organoid Characterization | Gastric organoids closely mirror the key structural attributes of human stomach tissue, recapitulating the morphology of the gastric epithelium with features such as gastric glands. They incorporate multiple cell lineages including parietal cells, chief cells, mucous cells, and enteroendocrine cells, faithfully representing the functional diversity of native gastric tissue. |
| Applications | They serve as valuable tools for personalized medicine and drug discovery applications. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.